News Archive - San Francisco AIDS Foundation

PrEP Facts: Introduction & FAQ

Learn more about Pre-Exposure Prophylaxis (PrEP) and how this HIV prevention strategy may be useful for you or someone you know.

Advocating for life-saving services delivered by syringe access programs

Laura Thomas, our director of harm reduction policy, testified to the House Committee on Appropriations for federal funding to expand services offered by syringe service programs.

The pain of racial injustice lingers. Here’s how you can support your Black partner.

"With all things in our unequal society, dating is harder for Black lives, too," writes Charles Orgbon III.

Microdosing hormones expands gender-affirming care options for non-binary folks

Kai Proschan explores how non-binary and transgender people have adopted low-dose gender-affirming hormone therapy in pursuit of their most authentic selves.

Cabotegravir for PrEP: Resistance, infections & more explained

Here's some info on the science behind this exciting new therapy, and a perspective on breakthrough infections and resistance mutations.

Gender-affirming surgeries linked to HIV viral suppression

New research with trans individuals enrolled in Medicaid finds that viral suppression increases after surgery, reinforcing the need for affordable, readily available gender-affirming care for all trans individuals.

5 Trans Activists Discuss the Complexities of “Visibility”

The challenge of visibility for transgender people is that once seen, they can be targeted. What does visibility mean if it comes at the cost of violence?

Medical Experts Encourage People Living with HIV Receive the COVID-19 Vaccine

Health officials agree that the COVID-19 vaccine is safe for people living with HIV and will slow the spread of the coronavirus.

Injectable PrEP Offers a New Option for Women

A recent study reveals that injectable cabotegravir could be an effective HIV prevention option for cisgender women.

HIV trends: ‘One-size-fits-all’ fails our communities

Although the number of new HIV infections declined again last year, other disparities continue -- and may only worsen with COVID-19.

The San Francisco Principles 2020: Addressing the unmet needs of long-term HIV survivors in San Francisco

Five long-term survivors outline the challenges they face and demands for inclusion, resources, and treatment that addresses the specific needs related to aging with HIV.

Does PrEP work for trans people taking gender-affirming hormones? Yes, says new research

People taking gender-affirming hormones may use PrEP with confidence, said Robert M. Grant, MD, MPH.

Have questions about bringing safe injection sites to San Francisco? Here’s some key info.

As momentum grows in bringing supervised consumption services to the Bay Area, know the facts about how these sites may impact our community.

I was denied donating plasma after COVID-19 because I’m Queer

Let’s call this what this is: discrimination against the LGBTQ community that only promotes shame and stigma.

“Tremendously exciting” news of cabotegravir long-acting injectable for PrEP shared at AIDS 2020

Final results of the HPTN 083 study show that for men who have sex with men and transgender women, a cabotegravir injection provided highly effective HIV prevention when given once every two months.

Filter by